Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of the combination therapy
of TTFields + SRS+ Temozolomide (TMZ) for newly diagnosed glioblastoma (GBM).